ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
98 583,69
0,49%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Onconetix Inc (ONCO)

  7. Onconetix Inc (ONCO) Actualités

ONCO

Onconetix (ONCO)

Onconetix Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ONCO
DateHeureSourceTitreSymboleSociété
17/12/202412h03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ONCOOnconetix Inc
13/12/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONCOOnconetix Inc
12/12/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCOOnconetix Inc
12/12/202423h00GlobeNewswire Inc.Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent FilingNASDAQ:ONCOOnconetix Inc
11/12/202423h11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ONCOOnconetix Inc
11/12/202412h24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ONCOOnconetix Inc
15/11/202417h25Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ONCOOnconetix Inc
15/11/202416h45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONCOOnconetix Inc
01/11/202422h06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ONCOOnconetix Inc
01/11/202421h56Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ONCOOnconetix Inc
31/10/202421h20Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:ONCOOnconetix Inc
18/10/202422h10Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:ONCOOnconetix Inc
17/10/202417h53Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ONCOOnconetix Inc
09/10/202423h16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONCOOnconetix Inc
03/10/202422h45GlobeNewswire Inc.Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditNASDAQ:ONCOOnconetix Inc
03/10/202415h05GlobeNewswire Inc.Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditNASDAQ:ONCOOnconetix Inc
01/10/202422h35Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:ONCOOnconetix Inc
01/10/202401h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCOOnconetix Inc
27/09/202421h54Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ONCOOnconetix Inc
26/09/202422h08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONCOOnconetix Inc
26/09/202412h16Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ONCOOnconetix Inc
20/09/202417h45GlobeNewswire Inc.Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of StockholdersNASDAQ:ONCOOnconetix Inc
03/09/202421h11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCOOnconetix Inc
29/08/202413h38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCOOnconetix Inc
01/08/202422h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ONCOOnconetix Inc
22/07/202423h00Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:ONCOOnconetix Inc
15/07/202412h00GlobeNewswire Inc.Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross ProceedsNASDAQ:ONCOOnconetix Inc
11/07/202414h17GlobeNewswire Inc.Onconetix Announces Exercise of Warrants for $1.11 Million Gross ProceedsNASDAQ:ONCOOnconetix Inc
13/02/202412h00GlobeNewswire Inc.Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of DirectorsNASDAQ:ONCOOnconetix Inc
18/12/202313h00GlobeNewswire Inc.Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™NASDAQ:ONCOOnconetix Inc
 Showing the most relevant articles for your search:NASDAQ:ONCO

Dernières Valeurs Consultées

BIT
UC1C56
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés